Traditional vs. Graft-augmented Posterior Colporrhaphy
Stopped early · Not applicable
Conditions studied: Pelvic Organ Prolapse, Posterior Vaginal Wall Defects
In brief
Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.
Key facts
- Study ID
- NCT00581594
- Run by
- University of California, Irvine
- People needed
- 8
- Starts
- 2006-01-01
- Expected to finish
- 2008-10-11
- Last updated by the study team
- 2021-01-25
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years old
- Posterior wall defect with point Ap or Bp at 0 or greater
- Desires surgical correction
- Willing to accept randomization to graft vs. no graft
- Competent to sign an informed consent
- Completed childbearing
- Non-pregnant
You may not qualify if…
- Current anal sphincter disruption with planned incontinent surgical repairs
- Poor surgical candidate
- History of rectal cancer or inflammatory bowel disease
- Current rectovaginal
- History of vaginal cancer
- History of vaginal/pelvic radiation
- Foreshortened vagina
- Previous adverse reaction to Xenform matrix graft material
Where it is running
- University of California, Irvine Medical Center — Orange, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.